Pilot implementation of Primer Capital’s portfolio project4 April 2018
Botkin.AI implements its AI-based clinical decision support system into a hospital located in the Murmansk Region.The developed solution is intended for diagnostics of oncological diseases at early stages, forecast of disease risks and even patient visits.
‘The first stage of our pilot project in Murmansk will cover implementation of an automatic retrospective review of CT chest images to detect lung cancer at early stages. We are also planning to expand the number of indications and modalities, as well as to provide assessment of disease risks based on electronic medical records,’ comments Sergey Sorokin, founder of Botkin.AI.
‘We invested in Botkin.AI last summer, and this round aimed to complete the development of cancer image recognition system. By now, the development is entering its implementation phase and will be used in real hospital settings, and it’s just the beginning. Botkin.AI is basically a new generation product, AI-as-a-Service for healthcare market, and Primer Capital is pleased to support this rapidly developing project of Russian biotech industry,’ says Elizaveta Rozhdestvenskaya, Primer Capital’s COO.
The target users of the platform are hospitals, healthcare authorities, pharmaceutical companies, contract research organizations and insurance companies.
Back to the list